Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 389 items for :

  • Refine by access: All content x
Clear All
Kathleen A Luckett Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Kathleen A Luckett in
Google Scholar
PubMed Close
,
Jennifer R Cracchiolo Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Jennifer R Cracchiolo in
Google Scholar
PubMed Close
,
Gnana P Krishnamoorthy Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Gnana P Krishnamoorthy in
Google Scholar
PubMed Close
,
Luis Javier Leandro-Garcia Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Luis Javier Leandro-Garcia in
Google Scholar
PubMed Close
,
James Nagarajah Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by James Nagarajah in
Google Scholar
PubMed Close
,
Mahesh Saqcena Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Mahesh Saqcena in
Google Scholar
PubMed Close
,
Rona Lester Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Rona Lester in
Google Scholar
PubMed Close
,
Soo Y Im Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Soo Y Im in
Google Scholar
PubMed Close
,
Zhen Zhao Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Zhen Zhao in
Google Scholar
PubMed Close
,
Scott W Lowe Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Scott W Lowe in
Google Scholar
PubMed Close
,
Elisa de Stanchina Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Elisa de Stanchina in
Google Scholar
PubMed Close
,
Eric J Sherman Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill-Cornell Medical College, New York, New York, USA

Search for other papers by Eric J Sherman in
Google Scholar
PubMed Close
,
Alan L Ho Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill-Cornell Medical College, New York, New York, USA

Search for other papers by Alan L Ho in
Google Scholar
PubMed Close
,
Steven D Leach Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Steven D Leach in
Google Scholar
PubMed Close
,
Jeffrey A Knauf Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Jeffrey A Knauf in
Google Scholar
PubMed Close
, and
James A Fagin Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill-Cornell Medical College, New York, New York, USA

Search for other papers by James A Fagin in
Google Scholar
PubMed Close

most prevalent form of the disease, are associated with clonal non-overlapping activating mutations of genes encoding MAPK pathway signaling effectors, primarily point mutations of BRAF and of the three RAS genes, as well as fusions of receptor

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-21-0017
Volume/Issue:
Volume 28: Issue 6
Open access
Samantha K McCarty Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Samantha K McCarty in
Google Scholar
PubMed Close
,
Motoyasu Saji Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Motoyasu Saji in
Google Scholar
PubMed Close
,
Xiaoli Zhang Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Xiaoli Zhang in
Google Scholar
PubMed Close
,
Christina M Knippler Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Christina M Knippler in
Google Scholar
PubMed Close
,
Lawrence S Kirschner Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine
Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Lawrence S Kirschner in
Google Scholar
PubMed Close
,
Soledad Fernandez Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Soledad Fernandez in
Google Scholar
PubMed Close
, and
Matthew D Ringel Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine
Division of Endocrinology, Department of Molecular Virology, Center for Biostatistics, Diabetes and Metabolism, Department of Internal Medicine

Search for other papers by Matthew D Ringel in
Google Scholar
PubMed Close

, invasion, and metastases is important in order to develop effective targeted therapies. PTC tumorigenesis is driven largely by activation of the MAP kinase pathway through several genetic events, the most common of which are activating mutations in BRAF

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-14-0424
Volume/Issue:
Volume 21: Issue 6
Free access
Matthias S Dettmer Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Matthias S Dettmer in
Google Scholar
PubMed Close
,
Anja Schmitt Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Anja Schmitt in
Google Scholar
PubMed Close
,
Hans Steinert Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Hans Steinert in
Google Scholar
PubMed Close
,
David Capper Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by David Capper in
Google Scholar
PubMed Close
,
Holger Moch Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Holger Moch in
Google Scholar
PubMed Close
,
Paul Komminoth Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Paul Komminoth in
Google Scholar
PubMed Close
, and
Aurel Perren Institute of Pathology, Division of Nuclear Medicine, Department of Neuropathology, Institute of Surgical Pathology, Institute of Surgical Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close

times their widths.’), and the percentage of tall cells (TCs) needed in a given tumor is defined variably in the literature ( Ostrowski & Merino 1996 , DeLellis et al . 2004 ). The oncogenic BRAF V600E mutation occurs in about 40–45% of PTCs

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-15-0057
Volume/Issue:
Volume 22: Issue 3
Free access
Luca Morandi Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology ‘M. Malpighi’ at Bellaria Hospital, University of Bologna, Bologna, Italy

Search for other papers by Luca Morandi in
Google Scholar
PubMed Close
,
Alberto Righi Department of Pathology, Rizzoli Institute, (IRCCS), Bologna, Italy

Search for other papers by Alberto Righi in
Google Scholar
PubMed Close
,
Francesca Maletta Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Francesca Maletta in
Google Scholar
PubMed Close
,
Paola Rucci Section of Hygiene and Biostatistics, University of Bologna, Bologna, Italy

Search for other papers by Paola Rucci in
Google Scholar
PubMed Close
,
Fabio Pagni Department of Pathology, University of Milano Bicocca, Monza, Italy

Search for other papers by Fabio Pagni in
Google Scholar
PubMed Close
,
Marco Gallo Oncological Endocrinology Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy

Search for other papers by Marco Gallo in
Google Scholar
PubMed Close
,
Sabrina Rossi Department of Pathology, Regional Hospital, Treviso, Italy

Search for other papers by Sabrina Rossi in
Google Scholar
PubMed Close
,
Leonardo Caporali Istituto delle Scienze Neurologiche di Bologna (IRCCS), Bellaria Hospital, Bologna, Italy

Search for other papers by Leonardo Caporali in
Google Scholar
PubMed Close
,
Anna Sapino Institute for Cancer Research and Treatment (IRCCS), Candiolo, Italy

Search for other papers by Anna Sapino in
Google Scholar
PubMed Close
,
Ricardo V Lloyd University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA

Search for other papers by Ricardo V Lloyd in
Google Scholar
PubMed Close
, and
Sofia Asioli Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology ‘M. Malpighi’ at Bellaria Hospital, University of Bologna, Bologna, Italy

Search for other papers by Sofia Asioli in
Google Scholar
PubMed Close

because the HPTC cells seem to be scarcely responsive to 131I treatment ( Haugen et al . 2016 ). To date, in PTC, the common known mutations are represented by several RET/PTC rearrangements ( Romei & Elisei 2012 ), BRAF p.V600 mutation ( Mathur et

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0546
Volume/Issue:
Volume 24: Issue 2
Free access
Christina M Knippler Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Christina M Knippler in
Google Scholar
PubMed Close
,
Motoyasu Saji Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Motoyasu Saji in
Google Scholar
PubMed Close
,
Neel Rajan College of Arts and Sciences, The Ohio State University, Columbus, Ohio, USA

Search for other papers by Neel Rajan in
Google Scholar
PubMed Close
,
Kyle Porter Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA

Search for other papers by Kyle Porter in
Google Scholar
PubMed Close
,
Krista M D La Perle Department of Veterinary Biosciences, Comparative Pathology & Mouse Phenotyping Shared Resource, The Ohio State University, Columbus, Ohio, USA

Search for other papers by Krista M D La Perle in
Google Scholar
PubMed Close
, and
Matthew D Ringel Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Matthew D Ringel in
Google Scholar
PubMed Close

AKT pathways occur frequently in thyroid cancers. The most common form of thyroid cancer, well-differentiated papillary thyroid cancer (PTC), is driven primarily by mutually exclusive mutations that activate MAPK signaling; ~60% have BRAF V600E

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-19-0188
Volume/Issue:
Volume 26: Issue 8
Free access
Tae Hyuk Kim Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed Close
,
Young-Eun Kim Green Cross Genome, Yongin, Korea

Search for other papers by Young-Eun Kim in
Google Scholar
PubMed Close
,
Soomin Ahn Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Soomin Ahn in
Google Scholar
PubMed Close
,
Ji-Youn Kim Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea

Search for other papers by Ji-Youn Kim in
Google Scholar
PubMed Close
,
Chang-Seok Ki Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Chang-Seok Ki in
Google Scholar
PubMed Close
,
Young Lyun Oh Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Young Lyun Oh in
Google Scholar
PubMed Close
,
Kyunga Kim Biostatistics and Clinical Epidemiology Center, Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Kyunga Kim in
Google Scholar
PubMed Close
,
Jae Won Yun Samsung Genome Institute, Samsung Medical Center, Seoul, Korea
Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea

Search for other papers by Jae Won Yun in
Google Scholar
PubMed Close
,
Woong-Yang Park Samsung Genome Institute, Samsung Medical Center, Seoul, Korea
Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea

Search for other papers by Woong-Yang Park in
Google Scholar
PubMed Close
,
Jun-Ho Choe Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed Close
,
Jung-Han Kim Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Jung-Han Kim in
Google Scholar
PubMed Close
,
Jee Soo Kim Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Jee Soo Kim in
Google Scholar
PubMed Close
,
Sun Wook Kim Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Sun Wook Kim in
Google Scholar
PubMed Close
, and
Jae Hoon Chung Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed Close

sarcoma viral oncogene homolog B ( BRAF ) T1799A mutation has drawn much attention based on its high prevalence, occurring in about 45% of PTC and 25% of ATC cases and its association with PTC recurrence ( Kim et al. 2012 , Xing et al. 2015 ). However

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0219
Volume/Issue:
Volume 23: Issue 10
Free access
M Xing Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument St/Suite 333 Baltimore, MD 21287, USA

Search for other papers by M Xing in
Google Scholar
PubMed Close

the most common and occurring mainly in PTC and some benign adenomas. The PAX8-PPAR γ occurs both in FTC and benign thyroid adenoma ( Cheung et al. 2003 , Sahin et al. 2005 ). The recently discovered activating mutation in BRAF (the gene for

Article Type:
Review Article
DOI:
https://doi.org/10.1677/erc.1.0978
Volume/Issue:
Volume 12: Issue 2
Free access
Avaniyapuram Kannan Murugan Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal, Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Search for other papers by Avaniyapuram Kannan Murugan in
Google Scholar
PubMed Close
,
Abeer Al-Amr Department of Microbiology, College of Science, Female Campus, King Saud University, Riyadh, Saudi Arabia

Search for other papers by Abeer Al-Amr in
Google Scholar
PubMed Close
,
Mysoon M Al-Ansari Department of Microbiology, College of Science, Female Campus, King Saud University, Riyadh, Saudi Arabia
Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Search for other papers by Mysoon M Al-Ansari in
Google Scholar
PubMed Close
,
Pulicat S Manogaran Department of Stem Cell Tissue Re-Engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Search for other papers by Pulicat S Manogaran in
Google Scholar
PubMed Close
,
Hindi Al-Hindi Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Search for other papers by Hindi Al-Hindi in
Google Scholar
PubMed Close
, and
Ali S Alzahrani Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal, Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Search for other papers by Ali S Alzahrani in
Google Scholar
PubMed Close

/PTC rearrangements, mutations in BRAF , NRAS , etc., and the PI3K/AKT pathway is activated mostly in poorly differentiated (PDTC) and anaplastic thyroid cancer (ATC) as a result of mutations in ALK , RAS , PIK3CA , AKT , etc. ( Murugan & Xing 2011 , Xing 2013

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-20-0242
Volume/Issue:
Volume 28: Issue 4
Restricted access
Yeon-Sook Choi Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Yeon-Sook Choi in
Google Scholar
PubMed Close
,
Hyemi Kwon Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Search for other papers by Hyemi Kwon in
Google Scholar
PubMed Close
,
Mi-Hyeon You Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Mi-Hyeon You in
Google Scholar
PubMed Close
,
Tae Yong Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Tae Yong Kim in
Google Scholar
PubMed Close
,
Won Bae Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Bae Kim in
Google Scholar
PubMed Close
,
Young Kee Shong Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Young Kee Shong in
Google Scholar
PubMed Close
,
Min Ji Jeon Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Min Ji Jeon in
Google Scholar
PubMed Close
, and
Won Gu Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Gu Kim in
Google Scholar
PubMed Close

. 2005 , Kurata et al. 2016 , Subbiah et al. 2018 , Kim et al. 2020 , Lee & Park 2021 ). The BRAF V600E mutation is one of the common genetic alterations in ATC, accounting for 20–50% of cases ( Xing 2013 , Jeon et al. 2016 , Subbiah et al

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0022
Volume/Issue:
Volume 29: Issue 6
Restricted access
Seo Ki Kim Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Seo Ki Kim in
Google Scholar
PubMed Close
,
Jung-Woo Woo Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Jung-Woo Woo in
Google Scholar
PubMed Close
,
Jun Ho Lee Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Jun Ho Lee in
Google Scholar
PubMed Close
,
Inhye Park Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Inhye Park in
Google Scholar
PubMed Close
,
Jun-Ho Choe Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed Close
,
Jung-Han Kim Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Jung-Han Kim in
Google Scholar
PubMed Close
, and
Jee Soo Kim Division of Breast and Endocrine Surgery, Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135‐710, South Korea

Search for other papers by Jee Soo Kim in
Google Scholar
PubMed Close

Introduction With a rapidly increasing incidence worldwide, papillary thyroid carcinoma (PTC) represents the majority of thyroid cancer cases ( Ahn & Park 2009 , Siegel et al . 2014 ). The recently discovered BRAF V600E mutation (hereafter

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-15-0408
Volume/Issue:
Volume 23: Issue 1
Free access